AzTrials
AzTrials

Mental Health Wellness 1Hope@SchoolNCT06359262

Evaluating the Hope@School Prevention Program

A study testing Hope@School and Treatment as usual in people with Mental Health Wellness 1, run by Karolinska Institutet.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This multi-center cluster-randomized controlled trial aims to evaluate the feasibility, effectiveness and overall impact of the Hope@School (H@S) program by comparing mental health outcomes in students participating in the H@S program with students having only access to regular student health care (treatment as usual… Read more about this study

Who is it for?
Ages 8 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Mental Health Wellness 1
What is being tested?
Hope@School and Treatment as usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,220 participants
Where
No sites listed yet
Study dates
1 Jan 2027to 30 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Age between 8 and 18 years
  • Attends school included in the study
  • Consents to participate

Who cannot join

  • Younger than 8 and older than 18 years

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Jens Högström, Ass. prof contact

0046 70 9689161

jens.hogstrom@ki.se

About this study

Official title: Feasibility, Effectiveness and Overall Impact of the Hope@School Universal Prevention Program Promoting Child and Adolescent Mental Health in Schools: A Two-arm Randomized Controlled Trial Across Seven European Countries

This multi-center cluster-randomized controlled trial aims to evaluate the feasibility, effectiveness and overall impact of the Hope@School (H@S) program by comparing mental health outcomes in students participating in the H@S program with students having only access to regular student health care (treatment as usual - TAU).

The primary objectives of the study are:

To determine if the H@S program is feasible, acceptable, usable and safe for students, families, teachers and school leaders To establish if the H@S program is associated with improvements in quality of life, everyday functioning, peer relations and general mental health.

Being tested
Hope@School, Treatment as usual

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hope@SchoolOther

    A digital platform aimed at promoting student mental health in schools

  • Treatment as usualOther

    Regular student health care in schools

Study groups in NCT06359262
Study groupRoleWhat they receive
Hope@SchoolExperimentalThe universal prevention program Hope@School. A digital platform with a number of tools that target mental health and wellbeing in children and adolescents.
Receives: Other: Hope@School
Treatment as usualActive comparatorRegular student health care in the schools
Receives: Other: Treatment as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. KIDSCREEN-27 Child version

    Level of child-rated quality of life as measured by a questionnaire

    Measured: Baseline, 3 month and 6 month (the 6 month assessment is the primary endpoint)

Secondary outcomes (5)
  1. KIDSCREEN-27 Parent version

    Level of parent-rated quality of life (the child's quality of life) as measured by a questionnaire

    Measured: Baseline, 3 month and 6 month (the 6 month assessment is the primary endpoint)

  2. Mental Health-Promoting Knowledge (MHPK-10)

    Level of child-rated mental health literacy as measured by a questionnaire

    Measured: Baseline, 3 month and 6 month (the 6 month assessment is the primary endpoint)

  3. Healthy Behaviours in School-aged Children survey protocol (HBSC) part 1

    Level of child-rated healthy behaviours as measured by a questionnaire

    Measured: Baseline, 3 month and 6 month (the 6 month assessment is the primary endpoint)

  4. Digital Addiction Scale for Children (DASC)

    Level of child-rated addictive digital behaviours as measured by a questionnaire

    Measured: Baseline, 3 month and 6 month (the 6 month assessment is the primary endpoint)

  5. Healthy Behaviours in School-aged Children survey protocol (HBSC) part 2

    Level of child-rated harmful digital practices as measured by a questionnaire

    Measured: Baseline, 3 month and 6 month (the 6 month assessment is the primary endpoint)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2024
  2. Study start1 Jan 2027 (estimated)
  3. Primary completion30 Dec 2027 (estimated)
  4. Study completion30 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
3,220 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06359262
Sponsor's protocol ID
KI-HAS-001
Acronym
Hope@School
Status last verified
Apr 2024
First submitted
2 Apr 2024
Last updated
11 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Hope@School and Treatment as usual in people with Mental Health Wellness 1, run by Karolinska Institutet.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jens Högström, Ass. prof (0046 70 9689161, jens.hogstrom@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

KIDSCREEN-27 Child version (time frame: Baseline, 3 month and 6 month (the 6 month assessment is the primary endpoint)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in